Table 1 Participant characteristics
No. | Age (years) | Gender | Ethnicity | BMI (kg /m2) | Months since HIV diagnosis | Days from HIV diagnosis to ART initiation | Months on ARTs | Current ART regimens | Months with HIV RNA < 50 copies/mL | Baseline CD4 counts (cells/μL) | Baseline CD8 counts (cells/μL) | Baseline CD4/CD8 ratios |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
01 | 29 | Male | Asian | 20.6 | 52.1 | 0 | 52.1 | ABC, 3TC, DTG | 45.3 | 304 | 571 | 0.5 |
02 | 28 | Male | Asian | 19.2 | 158.1 | 2570 | 72.5 | TAF, 3TC, DTG | 32.8 | 539 | 814 | 0.7 |
03 | 53 | Male | Asian | 28.1 | 39 | 19 | 38.4 | ABC, 3TC, DTG | 33.4 | 370 | 879 | 0.4 |
04 | 25 | Male | Asian | 21.9 | 35.9 | 251 | 27.6 | TDF, 3TC, EFV | 21.8 | 405 | 670 | 0.6 |
05 | 30 | Male | Asian | 22.7 | 57.1 | 54 | 55.3 | TDF, 3TC, EFV | 49.6 | 433 | 578 | 0.8 |
06 | 38 | Male | Asian | 30.0 | 111 | 1291 | 68 | TDF, 3TC, EFV | 49.2 | 633 | 1355 | 0.5 |
08 | 51 | Male | Asian | 25.1 | 103.6 | 197 | 97 | ABC, 3TC, DTG | 49.8 | 902 | 1462 | 0.6 |
09 | 34 | Male | Asian | 28.1 | 57.6 | 18 | 57 | TAF, FTC, DTG | 50.9 | 785 | 998 | 0.8 |
10 | 31 | Male | Asian | 25.0 | 62.1 | 26 | 61.3 | TDF, 3TC, LPV/r | 30.5 | 730 | 1319 | 0.6 |
11 | 33 | Male | Asian | 22.5 | 85 | 1311 | 41.3 | TDF, 3TC, EFV | 35.7 | 844 | 989 | 0.9 |
12 | 53 | Male | Asian | 18.4 | 144.5 | 23 | 143.7 | TDF, 3TC, EFV | 98.4 | 284 | 547 | 0.5 |
13 | 42 | Male | Asian | 26.9 | 25 | 0 | 25 | TDF, 3TC, EFV | 24.8 | 670 | 991 | 0.7 |
14 | 36 | Male | Asian | 21.7 | 75.6 | 41 | 74.2 | TDF, 3TC, EFV | 69 | 398 | 712 | 0.6 |
15 | 37 | Male | Asian | 20.7 | 198.7 | 735 | 174.2 | AZT, 3TC, EFV | 102.9 | 349 | 1074 | 0.3 |
16 | 38 | Male | Asian | 20.8 | 87.5 | 163 | 82.1 | TDF, 3TC, EFV | 76.3 | 327 | 444 | 0.7 |
Median (range) | 36 (25–53) | 22.5 (20.7–26.9) | 75.6 (25–198.7) | 54 (0–2570) | 61.3 (25–174.1) | 49.2 (21.8–102.9) | 433 (284–902) | 879 (444–1462) | 0.6 (0.3–0.9) |
